A Human ABCG2 SNP Variant, P269S (rs34678167, c.805C>T), Increases Cellular Resistance to Mitoxantrone and SN-38 Without Detectable Differences in ABCG2 Abundance in Total and Biotinylated Protein Fractions
- 1Department of Bioscience and Biotechnology, Graduate School of Bioscience and Biotechnology, Chubu University, 1200 Matsumoto-cho, Kasugai 487-8501, Japan
- 2Department of Biological Chemistry, Graduate School of Bioscience and Biotechnology, Chubu University, 1200 Matsumoto-cho, Kasugai 487-8501, Japan
Abstract
ABCG2 (BCRP/MXR) is an ATP-binding cassette transporter that plays a role in cellular resistance to various anticancer agents. While several non-synonymous single-nucleotide polymorphisms (SNPs) in the ABCG2 gene have been functionally characterized, the effects of many variants remain uncertain. This study examined the human ABCG2 SNP variant P269S (rs34678167, c.805C>T) in cellular resistance to mitoxantrone and SN-38 using a Flp-In-293 controlled expression system. Quantitative real-time PCR, whole-cell Western blotting, and cell-surface biotinylation analysis showed comparable ABCG2 mRNA and total protein levels and ABCG2 abundance in the biotinylated protein fraction between ABCG2(P269S)- and ABCG2(WT)-expressing cells. In MTT assays, ABCG2(P269S)-expressing cells exhibited significantly higher EC50 values than ABCG2(WT)-expressing cells, with mean values approximately 3.0- and 3.5-fold higher for mitoxantrone and SN-38, respectively. Consequently, P269S is associated with increased cellular resistance to mitoxantrone and SN-38 despite no detectable differences in total ABCG2 protein abundance or abundance in the biotinylated protein fraction. Collectively, these findings underscore the utility of the Flp-In-293 system for assessing variant-specific effects of ABCG2 on cellular drug responses within a controlled background. These results support future human pharmacogenomic research on rs34678167 to determine whether this variant contributes to inter-individual differences in responses to ABCG2 substrate drugs.
Related
- Association of intraoperative mitoxantrone hydrochloride injection with incidental parathyroidectomy and parathyroid autotransplantation during gasless unilateral axillary endoscopic thyroidectomy: a propensity score-matched retrospective cohort study
- The role of vascular resistance on coronary perfusion: differences between healthy and anomalous coronary origin under rest and exercise conditions
- Sex differences in dynamic cerebral autoregulation responses to resistance and endurance training in humans
- Myelolipoma Without Detectable Fat on Imaging Studies
- Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Autonomic Instability and Focal Seizures Without Detectable Ovarian Teratoma
BibTeX
@article{sato2026human,
title = {{A Human ABCG2 SNP Variant, P269S (rs34678167, c.805C>T), Increases Cellular Resistance to Mitoxantrone and SN-38 Without Detectable Differences in ABCG2 Abundance in Total and Biotinylated Protein Fractions}},
author = {Shiori Sato and Megumi Tsukamoto and Kayo Ozawa and Ritsuko Imai and Hiroshi Nakagawa},
journal = {Biomolecules},
year = {2026},
month = oct,
doi = {10.3390/biom16101486},
url = {https://www.mdpi.com/2218-273X/16/10/1486},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A Human ABCG2 SNP Variant, P269S (rs34678167, c.805C>T), Increases Cellular Resistance to Mitoxantrone and SN-38 Without Detectable Differences in ABCG2 Abundance in Total and Biotinylated Protein Fractions
AU - Shiori Sato
AU - Megumi Tsukamoto
AU - Kayo Ozawa
AU - Ritsuko Imai
AU - Hiroshi Nakagawa
PY - 2026
DA - 2026/10/01
JO - Biomolecules
DO - 10.3390/biom16101486
UR - https://www.mdpi.com/2218-273X/16/10/1486
AB - ABCG2 (BCRP/MXR) is an ATP-binding cassette transporter that plays a role in cellular resistance to various anticancer agents. While several non-synonymous single-nucleotide polymorphisms (SNPs) in the ABCG2 gene have been functionally characterized, the effects of many variants remain uncertain. This study examined the human ABCG2 SNP variant P269S (rs34678167, c.805C>T) in cellular resistance to mitoxantrone and SN-38 using a Flp-In-293 controlled expression system. Quantitative real-time PCR, whole-cell Western blotting, and cell-surface biotinylation analysis showed comparable ABCG2 mRNA and total protein levels and ABCG2 abundance in the biotinylated protein fraction between ABCG2(P269S)- and ABCG2(WT)-expressing cells. In MTT assays, ABCG2(P269S)-expressing cells exhibited significantly higher EC50 values than ABCG2(WT)-expressing cells, with mean values approximately 3.0- and 3.5-fold higher for mitoxantrone and SN-38, respectively. Consequently, P269S is associated with increased cellular resistance to mitoxantrone and SN-38 despite no detectable differences in total ABCG2 protein abundance or abundance in the biotinylated protein fraction. Collectively, these findings underscore the utility of the Flp-In-293 system for assessing variant-specific effects of ABCG2 on cellular drug responses within a controlled background. These results support future human pharmacogenomic research on rs34678167 to determine whether this variant contributes to inter-individual differences in responses to ABCG2 substrate drugs.
SN - 2218-273X
ER -